United Kingdom
News
Press Releases
Curaleaf International launches own range of Medical Cannabis Products in Germany
11 May 2021, London. Curaleaf International (formerly EMMAC Life Sciences Group), Europe’s largest vertically integrated cannabis company, is pleased to announce that its wholly
Novel Foods CBD Products Validation from the Foods Standards Agency
27 April 2021, London. Further to the announcement on 26 April 2021 that it received validation from the European Commission and European Food Safety
Cannabidiol Novel Foods Validation from the European Commission
26 April 2021, London. EMMAC Life Sciences Group, Europe’s largest vertically integrated cannabis company, is pleased to announce it has received validation from the
Curaleaf Completes Acquisition of EMMAC and Secures US$130 Million Investment from a Single Strategic Institutional Investor
WAKEFIELD, Mass., April 7, 2021 — Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer
EMMAC Life Sciences Group launches first Medical Cannabis Flower for UK Market
30 March 2021, London. EMMAC Life Sciences Group (‘EMMAC’), Europe’s largest independent cannabis company, is pleased to announce that its first range of unlicensed
Curaleaf to Enter European Cannabis Market with Acquisition of EMMAC Life Sciences Limited – Europe’s Leading Independent Cannabis Company
EMMAC Brings the Largest Vertically Integrated Independent Cannabis Company in Europe with a Presence in Key European Medical Cannabis Markets, Including the United Kingdom,
